Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.
Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.
In 2018, the global Cell-Free DNA (cfDNA) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cell-Free DNA (cfDNA) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell-Free DNA (cfDNA) Testing development in United States, Europe and China.
The key players covered in this study
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Market segment by Type, the product can be split into
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Market segment by Application, split into
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cell-Free DNA (cfDNA) Testing status, future forecast, growth opportunity, key market and key players.
To present the Cell-Free DNA (cfDNA) Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cell-Free DNA (cfDNA) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.
In 2018, the global Cell-Free DNA (cfDNA) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cell-Free DNA (cfDNA) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell-Free DNA (cfDNA) Testing development in United States, Europe and China.
The key players covered in this study
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Market segment by Type, the product can be split into
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Market segment by Application, split into
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cell-Free DNA (cfDNA) Testing status, future forecast, growth opportunity, key market and key players.
To present the Cell-Free DNA (cfDNA) Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cell-Free DNA (cfDNA) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
